Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.530
-0.050 (-3.16%)
At close: Oct 17, 2025, 4:00 PM EDT
1.580
+0.050 (3.27%)
After-hours: Oct 17, 2025, 6:49 PM EDT
Cerus Revenue
Cerus had revenue of $52.45M in the quarter ending June 30, 2025, with 16.34% growth. This brings the company's revenue in the last twelve months to $192.51M, up 13.25% year-over-year. In the year 2024, Cerus had annual revenue of $180.27M with 15.29% growth.
Revenue (ttm)
$192.51M
Revenue Growth
+13.25%
P/S Ratio
1.49
Revenue / Employee
$305,571
Employees
630
Market Cap
293.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 180.27M | 23.90M | 15.29% |
Dec 31, 2023 | 156.37M | -5.68M | -3.51% |
Dec 31, 2022 | 162.05M | 31.19M | 23.83% |
Dec 31, 2021 | 130.86M | 38.94M | 42.36% |
Dec 31, 2020 | 91.92M | 17.27M | 23.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CERS News
- 2 days ago - Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
- 7 weeks ago - The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions - Business Wire
- 2 months ago - Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025 - Business Wire
- 2 months ago - Cerus Corporation (CERS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cerus Corporation Announces Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025 - Business Wire
- 3 months ago - Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury - Business Wire
- 3 months ago - Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update - Business Wire